Overview

Prevention of Postoperative Bleeding in Subcapital Femoral Fractures

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
The main hypothesis of this clinical trial is that the use of intra-articular tranexamic acid and the fibrin glue plus usual hemostasis will reduce at least a 25% the postoperative blood loss with respect to usual hemostasis in patients undergoing subcapital femoral fractures.
Phase:
Phase 3
Details
Lead Sponsor:
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Treatments:
Fibrin Tissue Adhesive
Tranexamic Acid